Trinity Biotech Plc Stock Technical Analysis
| TRIB Stock | USD 1.81 0.07 3.72% |
As of the 23rd of April, Trinity Biotech has the Variance of 32.66, risk adjusted performance of (0.02), and Coefficient Of Variation of (2,015). In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Trinity Biotech plc, as well as the relationship between them. In other words, you can use this information to find out if the company will indeed mirror its model of past prices and volume data, or the prices will eventually revert. We were able to collect and analyze data for thirteen technical drivers for Trinity Biotech plc, which can be compared to its competition. Please validate Trinity Biotech plc variance and value at risk to decide if Trinity Biotech is priced more or less accurately, providing market reflects its prevalent price of 1.81 per share. Please also confirm Trinity Biotech plc jensen alpha, which is currently at (0.11) to double-check the company can sustain itself at a future point.
Trinity Biotech Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Trinity, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to TrinityTrinity |
Trinity Biotech Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 7.0 | Strong Buy | 1 | Odds |
Most Trinity analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Trinity stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Trinity Biotech plc, talking to its executives and customers, or listening to Trinity conference calls.
Trinity Biotech technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Trinity Biotech plc Technical Analysis
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Trinity Biotech plc volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Trinity Biotech plc Trend Analysis
Use this graph to draw trend lines for Trinity Biotech plc. You can use it to identify possible trend reversals for Trinity Biotech as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Trinity Biotech price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Trinity Biotech Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Trinity Biotech plc applied against its price change over selected period. The best fit line has a slop of 0.01 , which may suggest that Trinity Biotech plc market price will keep on failing further. It has 122 observation points and a regression sum of squares at 7.71, which is the sum of squared deviations for the predicted Trinity Biotech price change compared to its average price change.About Trinity Biotech Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Trinity Biotech plc on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Trinity Biotech plc based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Trinity Biotech plc price pattern first instead of the macroeconomic environment surrounding Trinity Biotech plc. By analyzing Trinity Biotech's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Trinity Biotech's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Trinity Biotech specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2023 | 2024 (projected) | Dividend Yield | 0.005862 | 0.006155 | Price To Sales Ratio | 0.0579 | 0.055 |
Trinity Biotech April 23, 2024 Technical Indicators
Most technical analysis of Trinity help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Trinity from various momentum indicators to cycle indicators. When you analyze Trinity charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.02) | |||
| Market Risk Adjusted Performance | 0.1336 | |||
| Mean Deviation | 3.35 | |||
| Coefficient Of Variation | (2,015) | |||
| Standard Deviation | 5.71 | |||
| Variance | 32.66 | |||
| Information Ratio | (0.06) | |||
| Jensen Alpha | (0.11) | |||
| Total Risk Alpha | (1.00) | |||
| Treynor Ratio | 0.1236 | |||
| Maximum Drawdown | 44.37 | |||
| Value At Risk | (6.87) | |||
| Potential Upside | 5.08 | |||
| Skewness | 3.92 | |||
| Kurtosis | 24.55 |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Trinity Biotech plc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Complementary Tools for Trinity Stock analysis
When running Trinity Biotech's price analysis, check to measure Trinity Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Trinity Biotech is operating at the current time. Most of Trinity Biotech's value examination focuses on studying past and present price action to predict the probability of Trinity Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Trinity Biotech's price. Additionally, you may evaluate how the addition of Trinity Biotech to your portfolios can decrease your overall portfolio volatility.
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |
Is Trinity Biotech's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Trinity Biotech. If investors know Trinity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Trinity Biotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.77) | Earnings Share (4.96) | Revenue Per Share 7.424 | Quarterly Revenue Growth (0.26) | Return On Assets (0.13) |
The market value of Trinity Biotech plc is measured differently than its book value, which is the value of Trinity that is recorded on the company's balance sheet. Investors also form their own opinion of Trinity Biotech's value that differs from its market value or its book value, called intrinsic value, which is Trinity Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Trinity Biotech's market value can be influenced by many factors that don't directly affect Trinity Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Trinity Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Trinity Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Trinity Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.